HomeInsightsStock Comparison

Dishman Carbogen Amcis Ltd vs Kopran Ltd Stock Comparison

Dishman Carbogen Amcis Ltd vs Kopran Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 254.85 as of 22 Jul 15:30.
  • The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 5.3 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Kopran Ltd changed from 5.2 on March 2020 to 24.5 on March 2024 . This represents a CAGR of 36.34% over 5 years.
  • The Market Cap of Dishman Carbogen Amcis Ltd changed from ₹ 840.79 crore on March 2020 to ₹ 3693 crore on March 2024 . This represents a CAGR of 34.45% over 5 yearsThe Market Cap of Kopran Ltd changed from ₹ 109.65 crore on March 2020 to ₹ 1245 crore on March 2024 . This represents a CAGR of 62.59% over 5 years.
  • The revenue of Dishman Carbogen Amcis Ltd for the Mar '25 is ₹ 724.31 crore as compare to the Dec '24 revenue of ₹ 690.01 crore. This represent the growth of 4.97% The revenue of Kopran Ltd for the Mar '25 is ₹ 175.62 crore as compare to the Dec '24 revenue of ₹ 166.41 crore. This represent the growth of 5.53%.
  • The ebitda of Dishman Carbogen Amcis Ltd for the Mar '25 is ₹ 148.91 crore as compare to the Dec '24 ebitda of ₹ 147.8 crore. This represent the growth of 0.75% The ebitda of Kopran Ltd for the Mar '25 is ₹ 20.35 crore as compare to the Dec '24 ebitda of ₹ 20.01 crore. This represent the growth of 1.7%.
  • The net profit of Dishman Carbogen Amcis Ltd changed from ₹ 17 crore to ₹ 43.09 crore over 8 quarters. This represents a CAGR of 59.21% The net profit of Kopran Ltd changed from ₹ 2.77 crore to ₹ 9.68 crore over 8 quarters. This represents a CAGR of 86.94% .
  • The Dividend Payout of Dishman Carbogen Amcis Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kopran Ltd changed from 55.28 % on March 2021 to 41.75 % on March 2024 . This represents a CAGR of -6.78% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dishman Carbogen Amcis Ltd

  • Dishman Carbogen Amcis Limited was formerly incorporated as 'Carbogen Amcis (India) Limited' on July 17, 2007.
  • The Company name later on, was changed to 'Dishman Carbogen Amcis Limited' on 27 March 2017.
  • The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants.
  • It works manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.
  • The name of Carbogen Amcis (India) Ltd.

About Kopran Ltd

  • Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises.
  • The company came out with a public issue at a premium, in Nov.'92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility. Kopran manufactures pharmaceutical finished dosage forms and bulk drugs and distributes electronic equipment.
  • It manufactures semi-synthetic penicillin and is among the world's highest producers in amoxycillin.
  • Kopran also makes penicillin-G acylase, an enzyme made through fermentation.
  • It has technical collaborations with Gesellschaft Fur Biotechnologische, Germany; Yuhan Corporation, South Korea; Ciba Corning Diagnostic, US; and Adac Laboratories, US. Kopran's bulk drug plant has been approved by the US FDA and the UK regulatory authorities.

Dishman Carbogen Amcis Ltd News Hub

News

Dishman Carbogen Amcis' Ahmedabad facility clears USFDA inspection without observations

The inspection was conducted from 9 June to 13 June 2025. According to the company's state...

Read more

16 Jun 2025 12:15

News

Carbogen Amic AG to co-invest in its manufacturing sites in Switzerland

Dishman Carbogen Amcis' wholly owned subsidiary, CARBOGEN AMCIS AG, a pharmaceutical proce...

Read more

06 Jun 2025 18:05

News

Dishman Carbogen spurts after turnaround Q4 outcome

Consolidated net sales rose 9.41% year-on-year to Rs 716.34 crore in Q4 March 2025. Pre-ta...

Read more

22 May 2025 12:16

News

Dishman Carbogen Amcis to hold board meeting

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 21 ...

Read more

17 May 2025 14:39

News

Dishman Carbogen Amcis' Shanghai facility clears China regulatory compliance

Dishman Carbogen Amcis announced that its Shanghai facility has successfully obtained its ...

Read more

21 Apr 2025 19:33

News

Dishman Carbogen Amcis receives affirmation in credit ratings

Dishman Carbogen Amcis has received affirmation in credit ratings from India Ratings and R...

Read more

16 Apr 2025 19:56

Kopran Ltd News Hub

News

Kopran to table results

Kopran will hold a meeting of the Board of Directors of the Company on 29 July 2025. Power...

Read more

19 Jul 2025 10:03

News

Board of Kopran recommends final dividend

Kopran announced that the Board of Directors of the Company at its meeting held on 15 May ...

Read more

15 May 2025 16:01

News

Kopran to hold board meeting

Kopran will hold a meeting of the Board of Directors of the Company on 15 May 2025. Powere...

Read more

07 May 2025 14:37

News

Kopran jumps as USFDA inspection at subsidiary's plant concludes smoothly

The United States Food and Drug Administration (USFDA) recently carried out a surveillance...

Read more

28 Apr 2025 15:03

News

Kopran to declare Quarterly Results

Kopran will hold a meeting of the Board of Directors of the Company on 11 February 2025. P...

Read more

05 Feb 2025 12:53

News

Kopran allots 36,200 equity shares under ESOP

Kopran has allotted 36,200 equity shares under ESOP on 21 January 2025. With this allotmen...

Read more

21 Jan 2025 18:36

SWOT Analysis Of Dishman Carbogen Amcis Ltd

Strength

1

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Kopran Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Dishman Carbogen Amcis Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Kopran Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dishman Carbogen Amcis Ltd and Kopran Ltd

Which company has a larger market capitalization, Dishman Carbogen Amcis Ltd or Kopran Ltd?

Market cap of Dishman Carbogen Amcis Ltd is 3,995 Cr while Market cap of Kopran Ltd is 854 Cr

What are the key factors driving the stock performance of Dishman Carbogen Amcis Ltd and Kopran Ltd?

The stock performance of Dishman Carbogen Amcis Ltd and Kopran Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dishman Carbogen Amcis Ltd and Kopran Ltd?

As of July 22, 2025, the Dishman Carbogen Amcis Ltd stock price is INR ₹254.85. On the other hand, Kopran Ltd stock price is INR ₹176.95.

How do dividend payouts of Dishman Carbogen Amcis Ltd and Kopran Ltd compare?

To compare the dividend payouts of Dishman Carbogen Amcis Ltd and Kopran Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions